VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $219,604 | -0.2% | 7,662 | -16.1% | 0.03% | -12.1% |
| Q3 2022 | $220,000 | -14.4% | 9,135 | -2.6% | 0.03% | -10.8% |
| Q2 2022 | $257,000 | -34.8% | 9,381 | -8.6% | 0.04% | -32.7% |
| Q1 2022 | $394,000 | +9.1% | 10,269 | -8.9% | 0.06% | +7.8% |
| Q4 2021 | $361,000 | -71.7% | 11,269 | -74.0% | 0.05% | -74.1% |
| Q3 2021 | $1,275,000 | +75.9% | 43,271 | +102.7% | 0.20% | +71.3% |
| Q2 2021 | $725,000 | -11.0% | 21,349 | -14.8% | 0.12% | -22.8% |
| Q1 2021 | $815,000 | -10.6% | 25,068 | -1.0% | 0.15% | -11.8% |
| Q4 2020 | $912,000 | -3.5% | 25,318 | +4.9% | 0.17% | -23.9% |
| Q3 2020 | $945,000 | +74.0% | 24,137 | +63.1% | 0.22% | +57.4% |
| Q2 2020 | $543,000 | +120.7% | 14,800 | +38.7% | 0.14% | +85.5% |
| Q1 2020 | $246,000 | – | 10,667 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |